All articles by Vidya Sagar
Vidya Sagar
Smith+Nephew announces new study showing GRAFIX™ Membrane cut the rate of diabetic foot ulcer recurrence in half compared to leading competitors
Smith+Nephew (LSE: SN,NYSE: SNN), the global medical technology business, announces the publication of a peer-reviewed study in the Advances in…
FDA approves CartiHeal’s Agili-C implant to treat cartilage and osteochondral defects
Israeli medical device maker CartiHeal has received the US Food and Drug Administration (FDA) premarket approval (PMA) for its Agili-C…
BillionToOne Closes $125M Series C Funding with Premier Global Investors
BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to…
Shockwave Medical Announces Japanese Regulatory Approval of Coronary IVL
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced…
Synchron’s BCI implant Stentrode safe for paralysis patients, says study
Implantable neural interface technology company Synchron has unveiled positive results for its brain computer interface (BCI) implant Stentrode from a…
MaximBio Reveals Agreement with US DoD for ClearDetect™ COVID-19 Antigen Home Test
Maxim Biomedical (MaximBio), a leading diagnostic healthcare company and manufacturer of trusted diagnostic solutions, revealed plans for fulfilling their newly…
Curi Bio Acquires CarTox™ Technology from StemBioSys, Announces Launch of Nautilus™ Optical Mapping System
Curi Bio, a leading developer of human stem cell-based platforms and technologies for drug discovery, today announced the exclusive commercial…
Biobeat gets FDA nod to measure additional vital signs with wearable RPM device
Biobeat has received 510(k) approval from the US Food and Drug Administration (FDA) for its wearable remote patient monitoring (RPM)…
Philips expands network of clinical partners to set new standard of care for the early diagnosis and treatment of lung cancer
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today provided an update on the growing global clinical…
STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the…